Vu Quan Anh — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Vu Quan Anh has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Vu Quan Anh

Vu Quan Anh is identified in SEC filings as the Chief Financial Officer of Monopar Therapeutics as of the filing date July 2, 2026. The available context provides his role and affiliation but does not publicly disclose further biographical details, education, or career history. There is no public record within the provided context indicating that he has passed away as of the filing date.

RoleChief Financial Officer
Notability25/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-02MNPRMonopar TherapeuticsF — Tax withholding / forfeiture507$92.59$47K
2026-07-02MNPRMonopar TherapeuticsM — Option exercise1.2K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Vu Quan Anh?

Vu Quan Anh is identified in SEC filings as the Chief Financial Officer of Monopar Therapeutics as of the filing date July 2, 2026. The available context provides his role and affiliation but does not publicly disclose further biographical details, education, or career history. There is no public record within the provided context indicating that he has passed away as of the fi…

How many SEC Form 4 filings has Vu Quan Anh submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Vu Quan Anh's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Vu Quan Anh profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.